Dr. Van den Hoogen studies on the interaction of human metapneumovirus and respiratory syncytial virus with the immune system are conducted with the aim to design novel antiviral therapies. These basic research lines are continuously supported by the development of novel assays in molecular biology, virology, genetics, and bioinformatics.